{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tildrakizumab",
          "name": "Tildrakizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_retinoids",
          "name": "Retinoids"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_retinoids",
          "type": "Drug",
          "label": "Retinoids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_target_immune_response",
          "type": "Target",
          "label": "Immune Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_pathway_inflammatory",
          "type": "Pathway",
          "label": "Inflammatory Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_pathway_cell_growth",
          "type": "Pathway",
          "label": "Cell Growth Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_pathway_apoptosis",
          "type": "Pathway",
          "label": "Apoptosis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_pathway_skin_health",
          "type": "Pathway",
          "label": "Skin Health Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_acitretin",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Retinoids often modulate immune response."
        },
        {
          "source": "t_target_immune_response",
          "target": "p_pathway_inflammatory",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Immune response is key in inflammatory pathways."
        },
        {
          "source": "p_pathway_inflammatory",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Inflammation is a significant aspect of psoriasis."
        },
        {
          "source": "drug_methotrexate",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Methotrexate is known to affect immune function."
        },
        {
          "source": "drug_cyclosporine",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.86,
          "agent": "Proponent",
          "rationale": "Cyclosporine targets immune system activity."
        },
        {
          "source": "drug_infliximab",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.88,
          "agent": "Proponent",
          "rationale": "Infliximab blockades TNF, crucial in psoriasis."
        },
        {
          "source": "drug_adalimumab",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.87,
          "agent": "Proponent",
          "rationale": "Adalimumab is a TNF inhibitor."
        },
        {
          "source": "drug_etanercept",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.87,
          "agent": "Proponent",
          "rationale": "Etanercept binds to TNF."
        },
        {
          "source": "drug_ustekinumab",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.84,
          "agent": "Proponent",
          "rationale": "Targets interleukin pathways."
        },
        {
          "source": "drug_tildrakizumab",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.82,
          "agent": "Proponent",
          "rationale": "Modulates IL-23."
        },
        {
          "source": "drug_apremilast",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.76,
          "agent": "Proponent",
          "rationale": "Inhibits phosphodiesterase, affecting immune responses."
        },
        {
          "source": "drug_secukinumab",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.79,
          "agent": "Proponent",
          "rationale": "Targets IL-17."
        },
        {
          "source": "drug_brodalumab",
          "target": "t_target_immune_response",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Inhibits IL-17 signaling."
        },
        {
          "source": "drug_retinoids",
          "target": "p_pathway_skin_health",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Retinoids enhance skin health."
        },
        {
          "source": "p_pathway_skin_health",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.72,
          "agent": "Proponent",
          "rationale": "Skin health is crucial in managing psoriasis."
        },
        {
          "source": "p_pathway_cell_growth",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Cell growth can be linked with psoriasis."
        },
        {
          "source": "p_pathway_apoptosis",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.68,
          "agent": "Proponent",
          "rationale": "Apoptosis is vital in skin health."
        },
        {
          "source": "drug_acitretin",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Acitretin's effects relate to immune modulation."
        },
        {
          "source": "drug_methotrexate",
          "target": "H2",
          "relation": "supports",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "Methotrexate's action supports the hypothesis."
        },
        {
          "source": "drug_cyclosporine",
          "target": "H3",
          "relation": "supports",
          "weight": 0.76,
          "agent": "Proponent",
          "rationale": "Supports immune modulation hypothesis."
        },
        {
          "source": "drug_etanercept",
          "target": "H4",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Aligns with psoriasis treatment expectations."
        },
        {
          "source": "drug_adalimumab",
          "target": "H5",
          "relation": "supports",
          "weight": 0.74,
          "agent": "Proponent",
          "rationale": "Consistent with TNF inhibiting effects."
        },
        {
          "source": "drug_infliximab",
          "target": "H6",
          "relation": "supports",
          "weight": 0.73,
          "agent": "Proponent",
          "rationale": "Fits with model of TNF inhibition."
        },
        {
          "source": "drug_ustekinumab",
          "target": "H7",
          "relation": "supports",
          "weight": 0.72,
          "agent": "Proponent",
          "rationale": "Validates the hypothesis by targeting IL-12/23."
        },
        {
          "source": "drug_tildrakizumab",
          "target": "H8",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Effective in IL-23 modulating."
        },
        {
          "source": "drug_apremilast",
          "target": "H9",
          "relation": "supports",
          "weight": 0.68,
          "agent": "Proponent",
          "rationale": "Aligns with autoimmune modulation."
        },
        {
          "source": "drug_secukinumab",
          "target": "H10",
          "relation": "supports",
          "weight": 0.67,
          "agent": "Proponent",
          "rationale": "Targets crucial inflammatory pathways."
        },
        {
          "source": "drug_brodalumab",
          "target": "H11",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Supports role in psoriasis treatment."
        },
        {
          "source": "drug_retinoids",
          "target": "H12",
          "relation": "supports",
          "weight": 0.64,
          "agent": "Proponent",
          "rationale": "Confirmed connection with skin health."
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过作用于免疫反应及炎症通路，可能改善广泛性脓疱性牛皮癣。",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物能够有效到达目标组织并发挥疗效（常识判断）"
    ],
    "uncertainties": [
      "药物在患者中特定的效果和安全性仍需进一步研究。"
    ],
    "next_focus_for_pi": [
      "确定是否需要进一步调查药物的具体作用机制和安全性。"
    ]
  }
}